We are live on ! Find out more
Jennison Associates

Jennison Associates Portfolio holdings

AUM $167B
1-Year Est. Return 44.17%
 

Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.

This Fund
S&P 500
This Quarter Est. Return
+6.63%
1 Year Est. Return
+44.17%
3 Year Est. Return
+189.18%
5 Year Est. Return
+274.73%
10 Year Est. Return
+1,810.99%
AUM
$109B
AUM Growth
+$4.27B
Cap. Flow
-$1.54B
Cap. Flow %
-1.41%
Top 10 Hldgs %
18.93%
Holding
796
New
64
Increased
297
Reduced
319
Closed
90

Top Buys

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$461M
2
QCOM icon
Qualcomm
QCOM
+$450M
3
MAR icon
Marriott International
MAR
+$341M
4
TIF
Tiffany & Co.
TIF
+$283M
5
NRG icon
NRG Energy
NRG
+$207M

Sector Composition

Rank Sector Weight
1 Healthcare 18.23%
2 Consumer Discretionary 14.87%
3 Energy 12.48%
4 Technology 11.83%
5 Communication Services 11.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMRN icon
76
BioMarin Pharmaceuticals
BMRN
$12.5B
$333M 0.31%
5,347,735
-2,672,017
-33% -$161M
AGN
77
DELISTED
Allergan plc
AGN
$318M 0.29%
1,425,739
-366,834
-20% -$76M
UHS icon
78
Universal Health Services
UHS
$10.1B
$318M 0.29%
3,318,911
-429,093
-11% -$37.1M
ESRX
79
DELISTED
Express Scripts Holding Company
ESRX
$301M 0.28%
4,343,471
-7,831,031
-64% -$551M
CCL icon
80
Carnival Corporation Ltd
CCL
$33.9B
$300M 0.28%
7,973,439
+11,710
+0.1% +$454K
JPM icon
81
JPMorgan Chase
JPM
$951B
$300M 0.28%
5,203,431
-1,000,381
-16% -$56.2M
XLNX
82
DELISTED
Xilinx Inc
XLNX
$291M 0.27%
6,149,542
+93,406
+2% +$4.5M
WP
83
DELISTED
Worldpay, Inc.
WP
$290M 0.27%
8,617,745
+249,019
+3% +$7.68M
ATVI
84
DELISTED
Activision Blizzard
ATVI
$285M 0.26%
12,786,885
-507,111
-4% -$10.4M
CCI icon
85
Crown Castle
CCI
$32.4B
$284M 0.26%
3,820,303
+82,230
+2% +$6.17M
SEMG
86
DELISTED
SEMGROUP CORPORATION
SEMG
$269M 0.25%
3,412,788
-170,780
-5% -$11.6M
FRC
87
DELISTED
First Republic Bank
FRC
$269M 0.25%
4,890,167
-158,579
-3% -$8.33M
SWN
88
DELISTED
Southwestern Energy Company
SWN
$266M 0.24%
5,845,006
-1,565
-0% -$72.5K
MPC icon
89
Marathon Petroleum
MPC
$104B
$265M 0.24%
6,777,324
+1,175,462
+21% +$52M
RS icon
90
Reliance Steel & Aluminium
RS
$19.8B
$262M 0.24%
3,555,292
-7,219
-0.2% -$519K
FLEX icon
91
Flex
FLEX
$40.8B
$262M 0.24%
31,407,916
-1,684,465
-5% -$12.7M
MRO
92
DELISTED
Marathon Oil Corporation
MRO
$261M 0.24%
6,529,709
+928,473
+17% +$34.3M
WMB icon
93
Williams Companies
WMB
$90.2B
$259M 0.24%
4,441,408
+1,840,333
+71% +$85.3M
HAIN icon
94
Hain Celestial
HAIN
$66.1M
$257M 0.24%
5,785,522
+139,538
+2% +$6.22M
MFA
95
MFA Financial
MFA
$893M
$257M 0.24%
7,813,507
+2,076,695
+36% +$67.1M
UAL icon
96
United Airlines
UAL
$35.9B
$254M 0.23%
6,186,730
+1,202,288
+24% +$51.8M
EA
97
DELISTED
Electronic Arts
EA
$249M 0.23%
6,940,307
+38,150
+0.6% +$1.24M
AMAT icon
98
Applied Materials
AMAT
$366B
$246M 0.23%
10,895,130
+1,609,704
+17% +$32.8M
MNDT
99
DELISTED
Mandiant, Inc. Common Stock
MNDT
$239M 0.22%
5,887,665
+548,093
+10% +$21.4M
HSIC icon
100
Henry Schein
HSIC
$9.98B
$237M 0.22%
5,094,956
+26,270
+0.5% +$1.2M

Similar funds

Jennison Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Jennison Associates held 796 positions worth $109B, up 4.1% from $105B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Jennison Associates's Q2 2014 filing shows 64 new, 297 increased, 319 reduced and 90 closed positions. Its largest new stake was Qualcomm: 5,657,444 shares worth $448M. The largest sale was Allergan Inc, an estimated $962M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Energy.

  • Jennison Associates's largest Q2 2014 buy was Qualcomm: 5,657,444 shares worth $448M.
  • Jennison Associates added most to SLB Ltd in Q2 2014, an estimated $461M increase.
  • Jennison Associates's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $962M.
  • Jennison Associates fully exited Estee Lauder in Q2 2014, selling an estimated $329M.
  • Jennison Associates's ten largest holdings make up 19% of its $109B portfolio in Q2 2014.
  • Jennison Associates opened 64 new positions and closed 90 in Q2 2014.
  • Jennison Associates's portfolio value rose 4.1% quarter-over-quarter to $109B.

Based on Jennison Associates's 13F filing for Q2 2014, filed 8 Aug 2014.